Nowadays, there is the new progress on genital herpes vaccine. The name of
vaccine is the therapeutic vaccines. This type of vaccine helps your body to
manage the HSV 2 virus replication such as transmission, lesion and viral
shedding. It is even more suggested approach to increase body immune system
rather than using antiviral drug. The therapeutic vaccination can be the
mediator of antiviral medication. Automatically it can increase the T cell
density and function and prevent virus replication process.
Vical is also developing plasmid DNA vaccine
technology that possible to induct the T cell response robust. It can be great
solution since genital herpes vaccine named plasmid DNA vaccine do not causing
any infection and be used repeatedly without generating antivector responses.
This vaccine will stimulate the T cell response. Partnering with Astellas Pharma,
Vical develop the bivalent plasmid DNA vaccine that makes you possible to
reduce the herpes virus named cytomegalovirus replication process.
The test that held to test this genital herpes
vaccine is trying to measure the HSV shedding rates before and after
vaccination process. It takes around 60 days to take the needed sample. When
the data is completely completed then it will compared. The viral shedding will
be measured during pre vaccination and after the intervention. The test result
showing that there is around 30% decreased rate of genital herpes spreading. So
basically, there are still hopes for the vaccine to deal with genital herpes
infection besides anti viral medication treatment.
